Iridian Asset Management’s Precigen PGEN Stock Holding History

Iridian Asset Management’s Portfolio PGEN Stock Details PGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-80,000	Closed	-$169K	–	58
2022 Q1	$169K	Sell	80,000 -30,000	-27%	-$73K	0.01%	51
2021 Q4	$408K	Buy	110,000 +60,000	+120%	+$258K	0.03%	69
2021 Q3	$250K	Hold	50,000	–	–	0.01%	81
2021 Q2	$326K	Buy	50,000 +20,000	+67%	+$140K	0.01%	96
2021 Q1	$207K	Sell	30,000 -1,000	-3%	-$8.45K	﹤0.01%	115
2020 Q4	$316K	Sell	31,000 -72,200	-70%	-$468K	0.01%	84
2020 Q3	$361K	Buy	103,200 +1,000	+1%	+$4.75K	0.01%	72
2020 Q2	$510K	Hold	102,200	–	–	0.01%	62
2020 Q1	$347K	Buy	+102,200	New	+$441K	0.01%	71

Other funds holding PGEN

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

LexAurum Advisors Overland Park, Kansas $866M AUM

LSA

Lansing Street Advisors Ambler, Pennsylvania $472M AUM 23.5% 1-Year Est. Return

KBC Group Brussels, Belgium $46.3B AUM 43.9% 1-Year Est. Return

GLR Partners Columbia, Maryland $215M AUM

IIWM

Investment Insight Wealth Management North Massapequa, New York $115M AUM

HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return

CSP

Cary Street Partners Richmond, Virginia $4.58B AUM 24% 1-Year Est. Return

State of New Jersey Common Pension Fund D Trenton, New Jersey $29.3B AUM 38.15% 1-Year Est. Return

CUAMC

China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

Iridian Asset Management's PGEN Position: Q2 2026 in Review

Iridian Asset Management increased its Precigen (PGEN) stake by 12% in Q2 2026, buying an estimated $1.9M and bringing the position to 4,031,963 shares worth $23M. The position accounts for 7.9% of the portfolio, ranked #4.

Iridian Asset Management first reported a position in PGEN in Q2 2014 and has held it in 49 quarters since. The position peaked at $131M in Q1 2016. 51 funds tracked by Wall St. Rank hold PGEN as of Q2 2026.

Iridian Asset Management held 4,031,963 shares of Precigen worth $23M as of Q2 2026.
Iridian Asset Management bought 439,233 Precigen shares in Q2 2026, an estimated $1.9M.
Precigen made up 7.9% of Iridian Asset Management's portfolio in Q2 2026, its #4 holding.
Iridian Asset Management first reported a position in Precigen in Q2 2014 and has held it in 49 quarters since.
Iridian Asset Management's Precigen position peaked at $131M in Q1 2016.
51 funds tracked by Wall St. Rank held Precigen as of Q2 2026.

Based on Iridian Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.